Syeda Ashna Fatima Kamal, MBBS, MD¹, Vivek Prakash^2*, Giuseppe Maiocco^3*, Mohammad Junaid Hussain, MD^4*, Ejaz Shah, MD⁴, Ishan Agarwal^5* and Ruchika Goel, MD, MPH^4*

¹Simmons Cancer institute at SIU SOM, southern university of illinois, Springfield, IL
²Southern University Of Illinois, Springfield, IL
³Southern Illinois University School of Medicine, Springfield, IL
⁴Division of Hematology/Oncology, Simmons Cancer Institute, Southern Illinois University School of Medicine, Springfield, IL
⁵University of chicago, Chicago, IL

Firas Baidoun, MD¹, Bradford Hoppe, MD, MPH^2*, Han Tun, MD¹ and Muhamad Alhaj Moustafa, MD¹

¹Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL
²Department of Radiation Oncology, Mayo Clinic, Jacksonville, FL

Masaaki Hotta, MD^1*, Ayako Iwama, MD^1*, Tokiko Hoshiyama, MD^1*, Yukie Tsubokura, MD, PhD^1*, Hideaki Yoshimura, MD^1*, Yumiko Kono, MD, PhD^2*, Shinya Fujita, MD, PhD^1*, Atsushi Satake, MD, PhD¹ and Tomoki Ito, MD, PhD¹

¹1st. Department of Internal medicine, Kansai Medical University, Hirakata, Japan
²Department of radiology, Kansai Medical University, Hirakata, Japan

Chun En Yau, MBBS^1*, Chen Ee Low, MBBS^1*, Lay Poh Khoo, BSc^2*, Whee Sze Ong, MAppStats^3* and Jianbang Chiang, MMed^2*

¹Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
²Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore
³Division of Clinical Trials and Epidemiological Sciences, National Cancer Centre Singapore, Singapore, Singapore

Nobuhiko Nakamura, MD, PhD^1,2*, Nobuhiro Kanemura, MD, PhD¹, Ryoma Shimazu, MD^1*, Takayuki Goto, MD^1*, Yuto Kaneda, MD, PhD^1*, Yoshikazu Ikoma, MD^1*, Takuro Matsumoto, MD, PhD^1*, Hiroshi Nakamura, MD, PhD^1,2* and Masahito Shimizu, MD, PhD^1,2*

¹Department of Hematology and Infectious Disease, Gifu University Hospital, Gifu, Japan
²Division of Transfusion Medicine and Cell Therapy, Gifu University Hospital, Gifu, Japan

Jonathan Keegan Bakos, MD¹, Silvia Escribano Serrat, MD², Yazeed Sawalha, MD³, Alison Moskowitz, MD⁴, Anna Crawford^1*, Taylor R. Brooks, MD^5*, Brian T. Hill, MD⁵, Ayo S Falade, MD, MBA⁶, Reid W. Merryman, MD⁶, Manali Kamdar, MD^7*, Andrew Ip, MD MSc⁸, Gunjan L. Shah, MD^9*, Arash Velayati, MD^1*, McKenzie Sorrell, DO¹, James A Davis, PharmD^1*, Irl Brian Greenwell, MD¹, Ann LaCasce, MD⁶ and Brian Hess, MD¹

¹Hollings Cancer Center, Medical University of South Carolina, Charleston, SC
²Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
³The James Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH
⁴Memorial Sloan Kettering Cancer Center, New York, NY
⁵Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Center, Cleveland, OH
⁶Dana-Farber Cancer Institute, Boston, MA
⁷University of Colorado Cancer Center, Aurora, CO
⁸Hackensack University Medical Center, Hackensack, NJ
⁹Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Jonathan R Day, MD, PharmD¹, Melissa C. Larson, MS^2*, Carla Casulo, MD³, Urshila Durani, MD, MPH⁴, Yucai Wang, MD, PhD⁴, Dai Chihara, MD, PhD⁵, Loretta J. Nastoupil, MD⁶, Brad S. Kahl, MD⁷, Peter Martin, MD⁸, Izidore S. Lossos, MD⁹, Jason T. Romancik, MD¹⁰, Amy Ayers, MPH^6*, Richard Burack, MD, PhD¹¹, Thomas M. Habermann, MD⁴, James R. Cerhan, MD, PhD¹², Christopher R. Flowers, MD, MS⁵, Matthew J. Maurer, DSc¹³ and Brian K. Link, MD^14*

¹Department of Internal Medicine, University of Iowa, Iowa City, IA
²Department of Quantitative Health Sciences, Mayo Clinic College of Medicine, Rochester, MN
³Wilmot Cancer Center, University of Rochester, Rochester, NY
⁴Division of Hematology, Mayo Clinic, Rochester, MN
⁵Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁶MD Anderson Cancer Center, Houston, TX
⁷Siteman Cancer Center, Division of Oncology, Washington University School of Medicine in St. Louis, Saint Louis, MO
⁸Weill Cornell Medicine, New York
⁹Sylvester Comprehensive Cancer Center, Division of Hematology, University of Miami School of Medicine, Miami, FL
¹⁰Department of Hematology and Medical Oncology, Winship Cancer Institute at Emory University, Atlanta, GA
¹¹University of Rochester, Rochester, NY
¹²Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
¹³Department of Health Sciences Research, Mayo Clinic, Rochester, MN
¹⁴Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA

Xavier Phina-Ziebin, MD^1*, Emmanuel Bachy, MD, PhD^2,3*, Francois Xavier Gros, MD^4*, Roberta Di Blasi, MD, PhD^5,6*, Charles Herbaux, MD, PhD^7*, Jacques-Olivier Bay, MD, PhD^8*, Sylvain Carras^9,10*, Pierre Bories, MD, PhD^11*, René-Olivier Casasnovas, MD^12*, Fabrice Jardin, MD PhD^13*, Franck Morschhauser, MD PhD¹⁴, Blandine Guffroy, MD^15*, Elodie Gat^16*, Julien Calvani, MD^17*, Marie Parrens, MD, PhD^18*, Elsa Poullot, MD^19*, Alexandra Traverse-Glehen, MD, PhD^20* and Louise Roulin, MD^21*

¹Lymphoid Malignancies Unit, Henri Mondor Hospital, APHP, CLAMART, CA, France
²Hematology Department, Lyon Sud Hospital, Pierre-Bénite, France
³Lyon-Sud Hospital Center, Pierre-Bénite, France
⁴CHU BORDEAUX, Merignac, FRA
⁵Hôpital Saint Louis, Paris, France
⁶Department of Hematology, Assistance Publique Hôpitaux de Paris - Hôpital Saint-Louis, University of Paris, PARIS, France
⁷Institute of Human Genetics, CNRS UM UMR 9002, University of Montpellier, MONTPELLIER, France
⁸Service d’hématologie, CHU Clermont-Ferrand, Clermont-Ferrand, France
⁹Hematology, CHU GRENOBLE - HÔPITAL ALBERT MICHALLON, Grenoble, France
¹⁰Hematology, Univ. Grenoble Alpes. Institute For Advanced Biosciences (INSERM U1209, CNRS UMR 5309), University Hospital, La Tronche, France
¹¹Early Phase Unit, University Cancer Institute Toulouse Oncopole, Toulouse, France
¹²Hematology Department, CHU Dijon, Dijon, France
¹³Centre Henri-Becquerel and University of Rouen, Rouen, France
¹⁴Hematology Department, Centre Hospitalier Régional Universitaire de Lille, Lille, AL, France
¹⁵Hematology department, INSTITUT DE CANCÉROLOGIE STRASBOURG EUROPE (ICANS), Strasbourg, FRA
¹⁶Institut Carnot CALYM, PIERRE-BENITE, FRA
¹⁷Pathology Department, Hopital Saint-Louis, PARIS, France
¹⁸Department of Pathology, University Bordeaux Hospital, Pessac, France
¹⁹Pathology Department, Henri Mondor Hospital, Creteil, France
²⁰Service de Pathologie Sud, Hospices Civils de Lyon, Pierre-Bénite, France
²¹Henri Mondor Hospital, APHP, Creteil, FRA

Sha He^1*, Jie Sun^2*, Dani Zhong^3*, Chao Rong^3*, Chengcheng Liao^2* and Xiaohong Tan^2*

¹Department of Haematology/Oncology and Paediatric Oncology, GuangxiGuangxi Medical University Affiliated Cancer Hospital, Nanning, Guangxi, China
²Guangxi Medical University Affiliated Cancer Hospital, Nanning, China
³Guangxi Medical University Affiliated Cancer Hospital, Nanning, Guangxi, China

Wenyue Sun, MBBS^1*, Shunfeng Hu^2*, Qiqi Qiao^2*, Bingyu Liu, MS^3* and Xin Wang, MD, PhD^2,4

¹Department of Hematology, Shandong Provincial Hospital, Shandong University, Jinan, AL, China
²Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China
³Department of Hematology, Shandong Provincial Hospital, Shandong University, Jinan,Shandong, AL, China
⁴Department of Hematology, Shandong Provincial Hospital, Shandong University, Jinan, China

Diana Al-Sarayfi^1*, Mirian Brink, PhD^2*, Mar Bellido, MD, PhD^3*, Wouter Plattel, MD, PhD^4*, Gerwin A. Huls, Prof.¹ and Marcel Nijland, MD, PhD^4*

¹Department of Hematology, University Medical Center Groningen, Groningen, Netherlands
²Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL),, Utrecht, NLD
³Department of Hematology, University Medical Center Groningen, Groningen, NLD
⁴Department of hematology, University Medical Center Groningen, Groningen, NLD

Allison M Lehanka^1*, Ann Kebede, MD², Neda Amirmokhtari, MD^3*, Joseph R Stanek, MS^4*, Narendranath Epperla, MD, MS⁵, Beth Christian, MD⁶, Robert Baiocchi, MD⁷, Timothy Voorhees, MD, MSCR⁶, Kami J. Maddocks, MD⁸, Yazeed Sawalha, MD⁶, John C Reneau, MD, PhD⁶, Jonathan E. Brammer, MD⁶, Audrey M. Sigmund, MD⁶, Faye Willen^9*, Nick Yeager, MD^10*, Anthony N. Audino, MD¹¹ and David A. Bond, MD, BS¹²

¹The Ohio State University College of Medicine, Columbus, OH
²The Hitchcock Wilson Pediatric Hematology/Oncology/BMT Fellowship, Nationwide Children’s Hospital, Columbus, OH
³Department of Internal Medicine, The Ohio State University, Columbus, OH
⁴Division of Biostatistics, Nationwide Children's Hospital, Columbus, OH
⁵The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH
⁶The James Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH
⁷Comprehensive Cancer Center, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH
⁸The James Cancer Center, Ohio State University Hospital, Columbus, OH
⁹Nationwide Children's Hospital, Columbus, OH
¹⁰Division of Hematology, Oncology, and Bone Marrow Transplant, Nationwide Children's Hospital, Columbus, OH
¹¹Hematology/Oncology/BMT, Nationwide Children's Hospital, Columbus, OH
¹²Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH

Sergio A. Vallejo, MD^1*, Victor Ramon Mendiola, MD², Joel Michalek, PhD^3*, Qianquian Liu, PhD^4* and Adolfo Enrique Diaz Duque, MD⁵

¹UTHSCSA, San Antonio, TX
²Mays Cancer Center, University of Texas Health Sciences Center of San Antonio, SAN ANTONIO, TX
³Department of Population Health Sciences, University of Texas Health-San Antonio, San Antonio, TX
⁴Department of Epidemiology and Biostatistics, University of Texas Health Science Center San Antonio, San Antonio, TX
⁵MD Anderson, University of Texas San Antonio, San Antonio, TX

Thais Fischer, MD^1,2*, Eliana C M CM Miranda, PhD, MEd^3*, Nelson Castro, MD^4*, Juliana Pereira, MD, PhD⁵, Davimar Miranda Maciel Borducchi, PhD⁶, Samuel de S Medina, MD^7*, Sergio Augusto B Brasil, MD, PhD^8*, Danielle Leao Cordeiro De Farias, MD, MSc, MBA⁹, Marcelo Bellesso, MD^10*, Jamila Vaz Tavarez, MD^11*, Karin Z Cecyn, MD^12*, Rony Schaffel, MD, PhD¹³, Samir Nabhan, MD^14*, Frederico Lisboa Nogueira, MD¹⁵, Renata Baptista, MD^16*, Fernando Barroso, MD^17*, Renata R Souza, MD^17*, Mateus Dalló Dal Pont, MD^18*, Carolina Colaço Vilarim, MD^19*, Claudio G Macedo, MD^19*, Ademar Dantas Cunha, PhD^20*, Patricia Giacon, MD^21*, Elizete Negreiros, MD^22*, Nelson Hamerschlak, MD, PhD²³, Vera Figueiredo, MD^24*, Diego Villa Cle, MD, MBA, PhD^25*, Natalia Pin Chuen Zing, MD, MSc^26,27*, Maria Almeida Dias, MD^28*, Rafael Gaiolla, MD, PhD^29*, Yung Bruno Gonzaga, MD^30*, Joao Tadeu Damian Souto Filho, MD^31*, Eduardo F O Ribeiro, MD^32*, Gilnara Fontinele Silva, MD^33*, Suellen Ka Gi Mo, MD^34*, Guilherme F Perini, MD^35*, Milena Matedi, MD^36*, Abrahão Elias Hallack Neto, MD, PhD^37*, Yana S Rabelo, MD^38*, Massimo Federico, MD³⁹, Carmino A Souza, MD^40* and Carlos Chiattone, MD, PhD^41,42*

¹Santa Casa de São Paulo Medical School, São Paulo, Brazil
²AC Camargo Cancer Center, Sao Paulo, AC, Brazil
³University of Campinas, Campinas, Brazil
⁴Hospital de Cancer de Barretos, Barretos, São Paulo, BRA
⁵University of São Paulo, Department of Hematology, Hemotherapy & Cell Therapy, University of São Paulo, São Paulo, São Paulo, Brazil
⁶CEPHO FMABC (Centro de Estudos e Pesquisa em Hematologia e Oncologia)/ Hospital Estadual Mario Covas - Faculdade de Medicina do ABC, Santo Andre, Brazil
⁷University of Campinas, São Paulo, BRA
⁸Santa Casa de São Paulo Medical School, Sao Paulo, Brazil
⁹Beneficencia Portuguesa Hospital, Sao Paulo, Brazil
¹⁰HemoMed, Sao Paulo, Brazil
¹¹Ophir Loyola Hospital, Belém, Brazil
¹²Federal University of Sao Paulo, Sao Paulo, Brazil
¹³HUCFF / UFRJ, Rio de Janeiro, Brazil
¹⁴Federal University of Paraná, Parana, Brazil
¹⁵Luxemburgo Hospital, Belo Horizonte, Brazil
¹⁶State of Rio de Janeiro University, Rio De Janeiro, Brazil
¹⁷Federal University of Ceara, Fortaleza, Brazil
¹⁸CEPON, Florianopolia, Brazil
¹⁹CECAN, Natal, Brazil
²⁰Hematology and Oncology Clinics, Cancer Hospital of Cascavel – UOPECCAN, Cascavel, Brazil
²¹Santa Marcelina Hospital, São Paulo, AL, BRA
²²Amor Amazônia Hospital, Porto Velho, Brazil
²³Albert Einstein Israelite Hospital, Sao Paulo, Brazil
²⁴Hospital do Servidor Público do Estado de São Paulo – IAMSPE. São Paulo – Brazil, Sao Paulo, Brazil
²⁵Ribeirao Preto Medical School - University of Sao Paulo, Ribeirao Preto, Brazil
²⁶Hospital Beneficencia Portuguesa de SP, Sao Paulo, Brazil
²⁷Prevent Senior, SAO PAULO, Brazil
²⁸Federal da Bahia Hospital, Salvador, Brazil
²⁹Hospital Das Clínicas UNESP, Botucatu, Brazil
³⁰Cancer National Institute- INCA, Rio de Janeiro, Brazil
³¹Campos Medical School, Rio da Janeiro, Brazil
³²Santa Lucia Hospital, Brasilia, Brazil
³³Aldenora Bello Hospital, Sao Luis, Brazil
³⁴Samaritano Hospital – Higienopolis, São Paulo, Brazil
³⁵Paulistano Hospital, Sao Paulo, Brazil
³⁶Santa Casa de Belo Horizonte, Belo Horizonte, Brazil
³⁷Juiz De Fora Federal University, Juiz de Fora, Brazil
³⁸Federal University of Goias, Goiania, Brazil
³⁹University of Modena and Reggio Emilia, Modena, Italy
⁴⁰University of Campinas, São Paulo, Brazil
⁴¹Santa Casa Medical School, Sao Paolo, Brazil
⁴²Samaritano Hospital, Sao Paulo, Brazil

Takuya Ueno^1*, Makoto Yoshimitsu, MD, PhD¹, Momone Sameshima^2*, Taichi Nagano, MD^1*, Rika Akahoshi, MD^1*, Yusetsu Takeshita, MD^1*, Aya Shodai, MD^1*, Kodai Shima, MD^1*, Naosuke Arima, MD^1*, Maiko Hayashida, MD^1*, Daisuke Nakamura, MD, PhD^1* and Kenji Ishitsuka, MD, PhD^1*

¹Department of Hematology and Rheumatology, Kagoshima University Hospital, Kagoshima, Japan
²Kagoshima University School of Medicine, Kagoshima, Japan

Daniela Urueta Portillo, MD^1*, Ian Mines, DO², Qianqian Liu, PhD^3*, Joel Michalek, PhD^3* and Adolfo Enrique Diaz Duque, MD⁴

¹University of Texas Health and Science Center at San Antonio, San Antonio, TX
²University of Texas Health Science Center at San Antonio, San Antonio, TX
³Department of Population Health Sciences, University of Texas Health-San Antonio, San Antonio, TX
⁴MD Anderson, University of Texas San Antonio, San Antonio, TX

Amy Chadburn, MD¹, Paul Rubinstein, MD^2*, Ethel Cesarman, MD, PhD³, Swarna Gogineni^4*, MIn Yang^5*, Maneeza Bilal, MS^6*, Nadine Demko, MD, CM, MSc^7*, Ivo N. Sah Bander, MD, PhD^7*, Chandler Sy, MD, PhD^7*, Victoria Alagiozian-Angelova, MD^8* and Liming Bao, MD, PhD⁹

¹Northwestern School Feinberg School of Medicine Northwester Memorial Hospital, New York, NY
²Division of Hematology/Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, IL
³Weill Cornell Medicine, New York
⁴New York Presbyterian Hospital, New York, NY
⁵Pathology and Laboratory Medicine, New York Presbyterian Hospital, New York, NY
⁶Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY
⁷Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY
⁸Pathology and Laboratory Medicine, John H. Stroger Hospital of Cook County, Chicago, IL
⁹Department ot Pathology, Weill Cornell Medicine, New York, NY

Ramsha Ahmed, MD^1*, Precious Anyanwu, MD^2*, Nirav N. Shah, MD¹, Mehdi Hamadani, MD³, Walter Longo, MD^4*, Sumana Devata, MD¹, Julie Pruett, APNP^5*, Jennifer Connelly, MD^6*, Joseph Bovi, MD^7*, Malika Siker, MD^7*, Christopher Schultz, MD^7* and Timothy S. Fenske, MD^1*

¹Medical College of Wisconsin, Milwaukee, WI
²Division of Internal Medicine/ Medical College of Wisconsin, Milwaukee, WI
³Division of Hematology and Oncology, The Medical College of Wisconsin Inc, Milwaukee, WI
⁴Medical College of Wisconsin, Division of Hematology/Oncology, Milwaukee, WI
⁵Froedtert Memorial Hospital, Milwaukee, WI
⁶Division of Neuro-Oncology/ Medical College of Wisconsin, Milwaukee, WI
⁷Division of Radiation Oncology/ Medical College of Wisconsin, Milwaukee, WI

Matthew J. Maurer, DSc¹, Arushi Khurana, MBBS², Raphael Mwangi, M.S.^2*, Grzegorz S. Nowakowski, MD³, Carla Casulo, MD⁴, Dai Chihara, MD, PhD⁵, Jonathon B. Cohen, MD, MS⁶, Brad S. Kahl, MD⁷, Izidore S. Lossos, MD⁸, Peter Martin, MD⁹, Yucai Wang, MD, PhD³, Timothy J. McDonnell, MD, PhD^10*, Andrew L. Feldman, MD¹¹, David L Jaye, MD¹², Thomas M. Habermann, MD³, James R. Cerhan, MD, PhD¹, Christopher R. Flowers, MD, MS¹³, Brian K. Link, MD^14* and Loretta J. Nastoupil, MD¹⁵

¹Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
²Mayo Clinic, Rochester, MN
³Division of Hematology, Mayo Clinic, Rochester, MN
⁴Wilmot Cancer Center, University of Rochester, Rochester, NY
⁵The University of Texas MD Anderson Cancer Center, Houston, TX
⁶Winship Cancer Institute, Emory University, Atlanta, GA
⁷Washington University School of Medicine in St. Louis, Saint Louis, MO
⁸Sylvester Comprehensive Cancer Center, Division of Hematology, University of Miami School of Medicine, Miami, FL
⁹Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY
¹⁰UT M.D. Anderson Cancer Center, Houston, TX
¹¹Department of Laboratory Medicine and Pathology, Division of Hematopathology, Mayo Clinic, Rochester, MN
¹²Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA
¹³Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁴University of Iowa, Iowa City, IA
¹⁵MD Anderson Cancer Center, Houston, TX

Benoît Tisserand^1*, Caroline Bret, PhD, PharmD^2,3*, Yassine Al Tabaa, MD, PhD, PharmD^4*, Sylvain Lamure, MD, PhD^1,5*, Xavier Ayrignac, MD, PhD^6*, Laura Platon, MD^7*, Patrice Ceballos, MD^1*, Ludovic Gabellier, MD, PhD^1,5*, Jerome Moreaux, PhD^2,8, Charles Herbaux, MD, PhD^1,2*, Guillaume Cartron, MD, Ph-D^9,10* and Jean-Jacques Tudesq, MD, MSc^1*

¹Clinical Hematology Department, Montpellier University Hospital, MONTPELLIER, France
²Institute of Human Genetics, CNRS UM UMR 9002, University of Montpellier, MONTPELLIER, France
³Dept. Biological Hematology, CHU Saint Eloi Hospital, MONTPELLIER, France
⁴Scintidoc Nuclear Medicine Center, Montpellier, France
⁵IGMM UMR 5535 CNRS UM, University of Montpellier, MONTPELLIER, France
⁶Neurology Department, Montpellier University Hospital, Montpellier, France
⁷Intensive Care Unit, Montpellier University Hospital, MONTPELLIER, France
⁸Laboratory for Monitoring Innovative Therapies, Department of Biological Hematology, Montpellier University Hospital, Montpellier, France
⁹Clinical Hematology Department, Montpellier University Hospital Center, Montpellier, France
¹⁰IGMM UMR 5535 CNRS UM, University of Montpellier, Montpellier, France

Charles Gaulin, MBBS¹, Shaykhah Alotaibi, MBBS^2*, Radhika Bansal, MBBS^3*, Daniel Huff, MD^4*, Madiha Iqbal, MD², Yucai Wang, MD, PhD⁵, Julio Cartagena^6*, Muhamad Alhaj Moustafa, MD⁷, Allison C. Rosenthal, DO⁸, Arushi Khurana, MBBS⁹, Hemant S. Murthy, MD¹⁰, Mazie Tsang, MD¹¹, Matthew J. Maurer, DSc¹², Talal Hilal, MD¹¹, Patrick B Johnston, MD, PhD^5*, Jonas Paludo, MD⁹, Jeanne Palmer, MD¹¹, Jose. C. Villasboas, MD^9*, Stephen M Ansell, MD, PhD⁵, Grzegorz S. Nowakowski, MD⁵, Januario E. Castro, MD⁸, Mohamed A. Kharfan-Dabaja, MD, MBA¹⁰, Yi Lin, MD, PhD³ and Javier L. Munoz¹³

¹Mayo Clinic, Scottsdale, AZ
²Mayo Clinic Florida, Jacksonville, FL
³Mayo Clinic Cancer Center, Rochester, MN
⁴Mayo Clinic Arizona, Phoenix, AZ
⁵Division of Hematology, Mayo Clinic, Rochester, MN
⁶University of Puerto Rico School of Medicine, San Juan, PR
⁷Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL
⁸Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ
⁹Mayo Clinic, Rochester, MN
¹⁰Department of Hematology/Oncology, Mayo Clinic, Jacksonville, FL
¹¹Mayo Clinic, Phoenix, AZ
¹²Department of Health Sciences Research, Mayo Clinic, Rochester, MN
¹³Department of Hematology, Mayo Clinic, Phoenix, AZ

Luke Eastburg, MD^1,2, Catherine S Forconi, PhD^3*, Sneha Makhijani, BS^4*, Oksana Kharabora, MS^4*, Edwards Kasonkanji, MPH^5*, Coxcilly Kampani^2*, Maria Chikasema, NMT^2*, Stephen M Kimani, MD, MSc^6*, Yuri D. Fedoriw, MD^2,4*, Johnathan J Juliano, MD, MSPH^4*, Ann Marie Moormann, PhD, MPH^7*, Satish Gopal, MD, MPH^8* and Matthew S Painschab, MD^2,4

¹University of North Carolina, Cary, NC
²UNC Project-Malawi, Lilongwe, Malawi
³Umass Medical School, Biotech II, WORCESTER, MA
⁴University of North Carolina, Chapel Hill, NC
⁵UNC Project, Lilongwe Malawi, Lilongwe, MWI
⁶University of Utah Huntsman Cancer Institute, Salt Lake City, UT
⁷Chan Medical School, University of Massachusetts, Worcester, MA
⁸National Cancer Institute, Rockville, MD

Kathryn Kline, MD¹, Caroline Dunne, MD^2*, Jennie Law, MD¹, Alonso Heredia, PhD^3*, Anthony Devico, PhD^3*, Mohammad Sajadi, MD^3*, Ben Atkinson, BS^3* and Seung Tae Lee, MD¹

¹University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD
²Lankenau Medical Center, Wynnewood, PA
³University of Maryland Institute of Human Virology, Baltimore, MD

Samantha J Mayo, PhD, RN^1,2*, Kim Edelstein, PhD, CPsych^2*, Lori Bernstein, PhD, CPsych^2*, Tiana Coley, BS^3*, Stacey Morrison, MSc^2*, Abi Vijenthira, MD, MS³, Manjula Maganti^4*, John Kuruvilla, MD, FRCPC³, Michael Crump, MD^3*, Sita D. Bhella, MD^3*, Robert Kridel³, Vishal Kukreti, MD, FRCP, MSc³, Chloe Yang, MD^3*, Shabbir MH Alibhai, MD, MSc^2*, Christine Chen, MHPE, MD, FRCPC³ and Anca Prica, MD, MSc^3*

¹Lawrence S. Bloomberg Faculty of Nursing, University of Toronto, Toronto, ON, Canada
²Department of Supportive Care, Princess Margaret Cancer Centre - University Health Network, Toronto, Canada
³Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre - University Health Network, Toronto, Canada
⁴Department of Biostatistics, Princess Margaret Cancer Centre - University Health Network, Toronto, Canada

Jennifer Kimberly Lue, MD¹, Efrat Luttwak, MD¹, Philip Caron, MD¹, Alexander P. Boardman^2*, Kevin A. David, MD^3*, Alfredo Rivas-Delgado^1*, Zachary D. Epstein-Peterson, MD¹, Lorenzo Falchi, MD¹, Paola Ghione, MD, MSEpi⁴, Paul A. Hamlin, MD³, Steven M. Horwitz, MD⁴, Andrew M. Intlekofer, MD, DPhil¹, William Johnson^4*, Anita Kumar, MD⁴, Alison Moskowitz, MD⁴, Ariela Noy, MD³, Maria Lia Palomba, MD¹, Robert Stuver, MD⁴, Pallawi Torka, MD¹, Santosha A Vardhana, MD, PhD^3*, Andrew D. Zelenetz, MD, PhD¹, Yanming Zhang, M.D.⁵, Pallavi Galera, MBBS⁶, Ahmet Dogan, MD, PhD⁷, Umut Aypar, PhD^5* and Gilles Salles, MD, PhD¹

¹Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
²Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
³Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York
⁴Memorial Sloan Kettering Cancer Center, New York, NY
⁵Cytogenetics Laboratory, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY
⁶Department of Pathology and Laboratory Medicine, Hematopathology Service, Memorial Sloan Kettering Cancer Center, New York
⁷Department of Pathology and Laboratory Medicine, Hematopathology Service, Memorial Sloan Kettering Cancer Center, New York, NY

Lorenzo Falchi, MD¹, Carmelo Carlo-Stella, Prof MD², Franck Morschhauser, MD PhD³, Michael Dickinson, MBBS, D. Med Sci, FRACP, FRCPA⁴, Emmanuel Bachy, MD, PhD^5*, Guillaume Cartron, MD, Ph-D^6*, Cyrus Khan, MD^7*, Monica Tani^8*, Joaquin Martinez-Lopez, MD, PhD^9*, Nancy L. Bartlett, MD¹⁰, Antonio Salar, MD^11*, Joshua Brody, MD^12*, Sirpa Leppä, MD PhD^13*, Aurelien Berthier, MD¹⁴, Martine Kallemeijn, PhD^14*, James Relf, MD^15*, Saibah Chohan, MSc^16*, Linda Lundberg, PhD^14* and Martin Hutchings, MD PhD^17*

¹Memorial Sloan Kettering Cancer Center, New York, NY
²Humanitas University and IRCCS Humanitas Research Hospital, Milan, Italy
³Hôpital Claude Huriez and CHU de Lille, Lille, France
⁴Peter MacCallum Cancer Centre, Royal Melbourne Hospital and The University of Melbourne, Melbourne, VIC, Australia
⁵Centre Hospitalier Lyon-Sud, Lyon, France
⁶CHU de Montpellier, Montpellier, France
⁷Allegheny Health Network, Pittsburgh, PA
⁸Ospedale Santa Maria delle Croci, Ravenna, Italy
⁹Hospital Universitario 12 de Octubre, Spanish National Cancer Research Center (CNIO), Complutense University Madrid, Madrid, Spain
¹⁰Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO
¹¹Hospital del Mar, Passeig Maritim, Barcelona, Spain
¹²Tisch Cancer Institute, New York, NY
¹³University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland
¹⁴F. Hoffmann-La Roche Ltd, Basel, Switzerland
¹⁵Roche Products Ltd, Welwyn Garden City, United Kingdom
¹⁶F. Hoffmann-La Roche Ltd, Mississauga, ON, Canada
¹⁷Rigshospitalet and University of Copenhagen, Copenhagen, Denmark

Zhang Hanzhen^1*, Xiaolei Wei, MD^1*, Wenlan Zhou^2*, Zihan Xu^1*, Junjie Chen^3*, Yongqiang Wei, MD^1*, Hubing Wu^2* and Ru Feng^1*

¹Department of Hematology, Nanfang Hospital of Southern Medical University, Guangzhou, China
²Nanfang PET Center, Nanfang Hospital of Southern Medical University, Guangzhou, China
³Southern Medical University/Hematology department, Guangzhou, China

Catherine Tang, MBBS, BSc, FRACP, FRCPA^1,2*, Lucy Zhang, MBBS^3*, Adam Suleman, MD^4,5, Katharine L. Lewis⁶, Daire Quinn, MBBCh^7*, Michelle Poon^8*, William Hann, MB BChir^9*, Edward Pringle, BM BCh^10*, Svetlana Cherepanoff, MBBS PhD FRCPA^11,12*, Luke Coyle, MBBS³, Shireen Kassam, FRCPath, MD, MBBS, PhD^10*, Pam McKay^13*, Chan Yoon Cheah, MD^14,15,16, Anca Prica, MD^4,5,17, Jeffery Smith, MBChB (Hons), B.Med.Sci., MRCP, FRCPath^18* and Nada Hamad, BSc MSc MBBS FRACP FRCPA^19,20

¹Department of Haematology, Gosford Hospital, Wahroonga, NSW, Australia
²School of Medicine and Public Health, The University of Newcastle, Callaghan, Australia
³Royal North Shore Hospital, Sydney, Australia
⁴Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada
⁵Department of Medicine, University of Toronto, Toronto, ON, Canada
⁶Department of Haematology, Sir Charles Gairdner Hospital, Perth, Australia
⁷Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom
⁸Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore
⁹Barts NHS Trust, London, United Kingdom
¹⁰King's College Hospital, London, United Kingdom
¹¹Sydpath St Vincent’s Hospital, Darlinghurst, Australia
¹²University of New South Wales, Kensington, Australia
¹³Haematology, Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom
¹⁴Medical School, University of Western Australia, Crawley, Western Australia, Australia
¹⁵Linear Clinical Research and Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia
¹⁶Linnear Clinical Research and Sir Charles Gairdner Hospital and University of Western Australia, Perth, Australia
¹⁷University Health Network, Toronto, ON, Canada
¹⁸Liverpool University Hospitals Foundation Trust, Liverpool, United Kingdom
¹⁹Haematology Department, The Kinghorn Cancer Centre, St Vincent's Hospital, Darlinghurst, NSW, Australia
²⁰The University of New South Wales, Kensington, NSW, Australia

David M. Kurtz, MD, PhD¹, Gregory Hogan, PhD^2*, Andre Schultz, PhD^2*, Jacob J. Chabon, PhD^2*, Ash A. Alizadeh, MD, PhD¹, Karin Havenith, PhD^3*, Sara Samari, PhD^3*, Tim Kopotsha, MSc^3*, Luqiang Wang, PhD^4*, Yajuan Qin, MD, PhD^4*, Ying Wang, MD, PhD⁴ and Serafino Pantano, PhD^5*

¹Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA
²Foresight Diagnostics, Aurora, CO
³ADC Therapeutics (UK) Ltd, London, United Kingdom
⁴ADC Therapeutics America, Inc, New Providence, NJ
⁵ADC Therapeutics SA, Epalinges, Switzerland

Jing Gao^1* and Liang Wang^2*

¹HEMATOLOGY, BEIJING TONGREN HOSPITAL, BEIJING, China
²Beijing Tongren Hospital, Guangzhou, China

Tommy Li, PhD^1*, Leonid Gibiansky, PhD^2*, Apurvasena Parikh, PhD^3*, Christopher W. Chiu, PhD¹, Mariana Sacchi, MD^1*, Huaibao Feng, PhD^1*, Tahi Ahmadi^1*, Manish Gupta, PhD^1* and Steven Xu, PhD^1*

¹Genmab, Plainsboro, NJ
²QuantPharm LLC, North Potomac, MD
³AbbVie Inc., South San Francisco, CA

David A Qualls, MD^1,2, Nicholas Lambert, MD³, Paolo F. Caimi, MD⁴, Mwanasha Hamuza Merrill, MD⁵, Priyanka Pullarkat, MD^6*, Richard C. Godby, MD⁷, David A. Bond, MD, BS⁸, Graham Wehmeyer, MD^9*, Jason T. Romancik, MD¹⁰, Behzad Amoozgar^11*, Lori A. Leslie, MD¹², Loretta J. Nastoupil, MD¹³, Jennifer L Crombie, MD⁵, Jeremy S. Abramson, MD¹⁴, Arushi Khurana, MBBS¹⁵, Grzegorz S. Nowakowski, MD⁷, Kami J. Maddocks, MD¹⁶, Sarah C. Rutherford, MD¹⁷, Brad S. Kahl, MD¹⁸, Michelle Okwali, MPH^19*, Michael Buege, PharmD²⁰, Venkatraman Seshan, PhD^20*, Connie Wing-Ching Lee Batlevi, MD, PhD^21,22 and Gilles Salles, MD, PhD^23,24

¹Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
²Division of Hematologic Malignancies, Dana Farber Cancer Institute, Boston, MA
³University of Texas Southwestern, Dallas, TX
⁴Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
⁵Dana Farber Cancer Institute, Boston, MA
⁶Department of Medicine, Massachusetts General Hospital, Boston, MA
⁷Division of Hematology, Mayo Clinic, Rochester, MN
⁸The James Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH
⁹Weill Cornell Medicine and New York Presbyterian Hospital, New York, NY
¹⁰Department of Hematology and Medical Oncology, Winship Cancer Institute at Emory University, Atlanta, GA
¹¹Washington University In St Louis, St Louis, MO
¹²Lymphoma Division, John Theurer Cancer Center, Hackensack Meridian School of Medicine, Hackensack, NJ
¹³MD Anderson Cancer Center, Houston, TX
¹⁴Massachusetts General Hospital Cancer Center, Boston, MA
¹⁵Mayo Clinic, Rochester, MN
¹⁶The James Cancer Center, Ohio State University Hospital, Columbus, OH
¹⁷Weill Cornell Medicine, New York, NY
¹⁸Washington University School of Medicine in St. Louis, Saint Louis, MO
¹⁹Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York
²⁰Memorial Sloan Kettering Cancer Center, New York, NY
²¹Genentech, South San Francisco, CA
²²Memorial Sloan Kettering Cancer Center, NEW YORK, NY
²³Department of Medicine, Weill Cornell Medical College, New York, NY
²⁴Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Lili Zhou^1*, Yifan Liu^1*, Shiguang Ye, MD^1*, Ping Li^1*, Shaoguang Li, MD² and Aibin Liang, MD, PhD^1*

¹Department of Hematology, Tongji Hospital of Tongji University, Shanghai, China
²Univ. of Massachusetts Medical School, Worcester, MA

Ning Dong, MD^1*, Hailing Zhang, MD^2*, Jinming Song, MD, PhD^3*, Jamila Mammadova^4*, Bijal D. Shah, MD⁵, Hayder Saeed, MD³, Ariel F. Grajales-Cruz, MD⁶, Leidy Lismeris Isenalumhe, MD, MS³, Sameh Gaballa, MD³, Celeste M. Bello, MD¹, Lubomir Sokol, MD, PhD¹, Javier Pinilla-Ibarz, MD, PhD³ and Julio C Chavez, MD¹

¹Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
²Department of Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
³H Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁴University of South Florida Morsani College of Medicine, Tampa
⁵Moffitt Cancer Center and Research Institute, Tampa, FL
⁶H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL

Wenbin Li^1*, Zhuang Kang^1*, Feng Chen^1*, Shenglan Li^1*, Xianggui Yuan^2*, Xi Chen^3*, Wenbin Qian^2*, Haiyan Yang⁴, Miao Hu⁵ and Xinglu Zhou^5*

¹Department of Neuro-oncology, Cancer Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
²Department of Hematology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
³Department of Lymphatic Oncology, Zhejiang Cancer Hospital, Hangzhou, China
⁴Department of Lymphoma, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China
⁵HealZen Therapeutics Co., Ltd, Hangzhou, China

Prokop Vodicka^1*, Michal Masar, MD^1*, Magdalena Klanova, MD, PhD^1*, Katerina Benesova, MD, CSc^1*, Jan Koren, MD^1*, Pavel Klener, Prof., MD, PhD^1*, Petra Blahovcova^1,2*, Sarka Hrabetova^1*, Jitka Dlouha^1,2* and Marek Trněný, MD^1,2

¹First Department of Medicine, First Faculty of Medicine, Charles University and General Hospital, Prague, Czech Republic
²Czech Lymphoma Study Group, Prague, Czech Republic

Akhil Rajendra, MD, MBBS, DM^1*, Alok Shetty, MD, DM^2*, Anu Korula, MD, DM^3*, Hasmukh Jain, MD, DM^4*, Mobin Paul, M.D, D.M^5*, Prasanth Ganesan, M.D, D.M^6*, Jayachandran Perumal Kalaiyarasi, MD, MBBS, DM, MRCP^7*, Santhosh Kumar Devadas^8*, Sushil Selvarajan, MD, DM^3*, Abhilash Menon, MD^9*, Divya K^10*, Parathan Karunakaran, MD, DM^11*, Lingaraj Nayak, MBBS, MD, DM^12*, Om Prakash^13*, Bhausaheb Bagal, MD, DM^2*, Aby Abraham, MD, DM^14*, Prasanna Samuel^10* and Uday Kulkarni, MD, DM¹⁵

¹Cancer Institute WIA, Toronto, ON, Canada
²Department of Medical Oncology, Tata Memorial Centre, Mumbai, India
³Department of Haematology, Christian Medical College Vellore, Vellore, India
⁴Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India
⁵Department of Clinical Haematology & Hemato - Oncology, Rajagiri Hospital, Kochi, India
⁶Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India
⁷Cancer Institute WIA, Chennai, India
⁸Medical Oncology, Ramaiah Medical College & Hospital, Bengaluru, IND
⁹Medical Oncology, Malabar Cancer Centre, Thalassery, IND
¹⁰Biostatistics, Christian Medical College, Vellore, India
¹¹Cancer Institute (WIA), Chennai, India
¹²Department of Medical Oncology, Tata Memorial Centre, MUMBAI, India
¹³CDMC, Christian Medical College, Vellore, India
¹⁴Department of Haematology, Christian Medical College Vellore, Vellore, Tamil Nadu, India
¹⁵Department of Haematology, Christian Medical College Vellore, Ranipet, India

Geoffrey P. Shouse, PhD, DO¹, Kristie A. Blum, MD², Julie E. Haydu, MD PhD^3*, Jeremy S. Abramson, MD³, Mayur Narkhede, MD^4*, Andrew Ip, MD MSc⁵, Jennifer S. Michaelson, PhD^6*, Patrick A. Baeuerle, PhD^6*, Kristan Meetze, PhD^6*, Irina Shapiro, PhD^6*, Todd Shearer, PhD, MS⁶, Judith Inumerable, MBEE^6*, Jeff Jones, MD MPH MBA^6* and Farrukh T. Awan, MD⁷

¹Hematology/HCT, City of Hope National Medical Center, Duarte, CA
²Winship Cancer Institute of Emory University, Atlanta, GA
³Massachusetts General Hospital Cancer Center, Boston, MA
⁴University of Alabama at Birmingham, Birmingham, AL
⁵Hackensack University Medical Center, Hackensack, NJ
⁶Cullinan Oncology, Inc., Cambridge, MA
⁷University of Texas Southwestern Medical Center, Dallas, TX

Christian Grommes, MD^1*, Grzegorz S. Nowakowski, MD², Allison C. Rosenthal, DO³, Matthew A. Lunning, DO, FACP^4*, Radhakrishnan Ramchandren, MD⁵, Lucia Regales, PhD^6*, Meaghan Fowle, BSc^6*, Maureen Lane, PhD^6*, Catherine Wang, MD^6*, Antonio Omuro, MD^7*, Lori A. Leslie, MD⁸, Carole Soussain, MD⁹, Anna Paulina Dabrowska-Iwanicka, MD¹⁰, Andrés José María Ferreri, MD¹¹ and Han Tun, MD¹²

¹Department of Neurology, Memorial Sloan Kettering Cancer, New York, NY
²Division of Hematology, Mayo Clinic, Rochester, MN
³Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ
⁴University of Nebraska Medical Center, Omaha, NE
⁵University of Tennessee Medical Center, Knoxville, TN
⁶Curis Inc., Lexington, MA
⁷Yale New Haven Hospital, New Haven, CT
⁸Lymphoma Division, John Theurer Cancer Center, Hackensack Meridian School of Medicine, Hackensack, NJ
⁹Hôpital René Huguenin - Institut Curie, Saint-Cloud, FRA
¹⁰Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology, Warszawa, Poland
¹¹Unit of Lymphoid Malignancies, Department of Onco-Haematology, IRCCS San Raffaele Scientific Institute, Milano, Italy
¹²Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL

Willem Klaassen^*, Timo K. van den Berg, PhD^*, Evelyn van den Tweel, PhD^*, Henricus Van Hooren, MSc^* and Jan Schellens, MD^*

Byondis, Nijmegen, Netherlands